The clinical course of symptomatic deep vein thrombosis after 3 months of anticoagulant therapy using fondaparinux/edoxaban or fondaparinux/vitamin K antagonist

Kazuhiro Shimizu; Takuo Iiduka; Shuji Sato; Hajime Kiyokawa; Takahiro Nakagami; Hiroshi Mikamo; Masayo Kawazoe; Mao Takahashi; Mahito Noro

doi:10.2147/TCRM.S153517

open access to scientific and medical research

Back to Journals » Therapeutics and Clinical Risk Management » Volume 14

Original Research

The clinical course of symptomatic deep vein thrombosis after 3 months of anticoagulant therapy using fondaparinux/edoxaban or fondaparinux/vitamin K antagonist

Total article views		HTML views	PDF downloads	Totals
8,702	Dovepress*	8,250+	1,383	9,633
	PubMed Central*	452	127	579
	Totals	8,702	1,510	10,212
*Since 23 February 2018

View citations on PubMed Central and Google Scholar

In order to provide our website visitors and registered users with a service tailored to their individual preferences we use cookies to analyse visitor traffic and personalise content. You can learn about our use of cookies by reading our Privacy Policy. We also retain data in relation to our visitors and registered users for internal purposes and for sharing information with our business partners. You can learn about what data of yours we retain, how it is processed, who it is shared with and your right to have your data deleted by reading our Privacy Policy.

If you agree to our use of cookies and the contents of our Privacy Policy please click 'accept'.